» Articles » PMID: 36614925

Psychological Characteristics and Quality of Life of Patients with Upper and Lower Functional Gastrointestinal Disorders

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Jan 8
PMID 36614925
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to identify the differences in the psychological characteristics of the anatomical location of functional gastrointestinal disorders (FGIDs) and the factors that influence the quality of life (QOL). Methods: Altogether, 233 patients with FGIDs were classified into the upper gastrointestinal disorder (UGID; n = 175) group and the lower gastrointestinal disorder group (LGID; n = 58). Psychological characteristics and QOL were evaluated using the validated questionnaires. Results: The LGID group demonstrated higher scores in ‘emotional depression’ than the UGID group in depressive symptoms (t = −3.031, p < 0.01). A significant difference was observed between groups in ‘significant others’ in social supports (t = 2.254, p < 0.05). Significant differences were observed between the groups in hardiness (t = 2.259, p < 0.05) and persistence (t = 2.526, p < 0.05) in resilience, while the LGID group demonstrated significantly lower scores than the UGID group in ‘negative affectivity’ in type-D personality (t = −1.997, p < 0.05). Additionally, the LGID group demonstrated lower QOL than the UGID group (t = 2.615, p < 0.05). The stepwise regression analysis on QOL involved depression, resilience, social support, and childhood trauma, which accounted for 48.4% of the total QOL explanatory variance. Conclusions: Psychological characteristics and QOL significantly differed when FGIDs were classified according to anatomical location. Thus, psychological interventions customized for each type of FGIDs may be necessary for effective treatment.

Citing Articles

Gut-Brain Axis and Psychopathology: Exploring the Impact of Diet with a Focus on the Low-FODMAP Approach.

Ribichini E, Scalese G, Mocci C, Severi C Nutrients. 2024; 16(20).

PMID: 39458509 PMC: 11510627. DOI: 10.3390/nu16203515.

References
1.
Lee C, Doo E, Choi J, Jang S, Ryu H, Lee J . The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil. 2017; 23(3):349-362. PMC: 5503284. DOI: 10.5056/jnm16220. View

2.
Sanders D, Carter M, Hurlstone D, Pearce A, Ward A, McAlindon M . Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001; 358(9292):1504-8. DOI: 10.1016/S0140-6736(01)06581-3. View

3.
Paul Galmiche J, Clouse R, Balint A, Cook I, Kahrilas P, Paterson W . Functional esophageal disorders. Gastroenterology. 2006; 130(5):1459-65. DOI: 10.1053/j.gastro.2005.08.060. View

4.
Joyce S, Shand F, Tighe J, Laurent S, Bryant R, Harvey S . Road to resilience: a systematic review and meta-analysis of resilience training programmes and interventions. BMJ Open. 2018; 8(6):e017858. PMC: 6009510. DOI: 10.1136/bmjopen-2017-017858. View

5.
Luthar S, Cicchetti D, Becker B . The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 2000; 71(3):543-62. PMC: 1885202. DOI: 10.1111/1467-8624.00164. View